Lack of CD8+ T cell effector differentiation during priming mediates checkpoint blockade resistance in non–small cell lung cancer

BL Horton, DM Morgan, N Momin, M Zagorulya… - Science …, 2021 - science.org
In non–small cell lung cancer (NSCLC), response to immune checkpoint blockade (ICB) is
associated with programmed cell death ligand 1 expression that is induced by interferon-γ …
被引用次数：87 相关文章

[引用][C] Lack of CD8 + T cell effector differentiation during priming mediates checkpoint blockade resistance in non–small cell lung cancer

BL Horton, DM Morgan, N Momin, M Zagorulya… - Science …, 2021 - cir.nii.ac.jp
Lack of CD8 <sup>+</sup> T cell effector differentiation during priming mediates checkpoint
blockade resistance in non–small cell lung cancer | CiNii Research CiNii 国立情報学研究所 学術 …
[HTML] nih.gov

[HTML][HTML] Lack of CD8+ T cell effector differentiation during priming mediates checkpoint blockade resistance in non–small cell lung cancer

BL Horton, DM Morgan, N Momin, M Zagorulya… - Science …, 2021 - ncbi.nlm.nih.gov
In non–small cell lung cancer (NSCLC), response to immune checkpoint blockade (ICB) is
associated with programmed cell death ligand 1 expression that is induced by interferon-γ …

Lack of CD8+ T cell effector differentiation during priming mediates checkpoint blockade resistance in non–small cell lung cancer.

BL Horton, DM Morgan, N Momin… - Science …, 2021 - search.ebscohost.com
In non–small cell lung cancer (NSCLC), response to immune checkpoint blockade (ICB) is
associated with programmed cell death ligand 1 expression that is induced by interferon-γ …

Lack of CD8+ T cell effector differentiation during priming mediates checkpoint blockade resistance in non-small cell lung cancer.

BL Horton, DM Morgan, N Momin, M Zagorulya… - Science …, 2021 - europepmc.org
In non–small cell lung cancer (NSCLC), response to immune checkpoint blockade (ICB) is
associated with programmed cell death ligand 1 expression that is induced by interferon-γ …

Lack of CD8+ T cell effector differentiation during priming mediates checkpoint blockade resistance in non-small cell lung cancer

BL Horton, DM Morgan, N Momin… - Science …, 2021 - pubmed.ncbi.nlm.nih.gov
In non–small cell lung cancer (NSCLC), response to immune checkpoint blockade (ICB) is
associated with programmed cell death ligand 1 expression that is induced by interferon-γ …